Ed M. Perry

Enerkem, Inc. develops renewable biofuels and chemicals from waste. It is a gasification technology company specializing in converting low and negative value waste stream into liquid alcohols used for transportation fuels. The firm through the combination of a proprietary thermo chemical technology platform and community-based facilities addresses the oil dependence and waste disposal. The company was founded by Vincent Chornet and Esteban Chornet in 2000 and is headquartered in Montr?al, Canada.

Crescendo Management LLC (Crescendo Ventures) is a venture capital firm founded in 1993 by David Spreng, Mitchell Dann and Jeff Tollefson. The firm is headquartered in Palo Alto, California.

Part of Federated Hermes, Inc., Investment Advisers, Inc. is a company that provides investment and other related financial services. The company is based in Bloomington, MN. Investment Advisers was acquired by Federated Hermes, Inc. from Lloyds TSB Group Plc on September 20, 2000.

Oncotherapeutics, Inc. develops and manufactures therapeutic cancer drugs and biomarkers. The firm is a service contract research organization (CRO) with a unique focus on the oncology therapeutic area. Its program encompasses laboratory research, protocol concept, design and development, clinical trial management, monitoring, data management, biostatistics, safety review, clinical and database auditing, medical monitoring, and medical writing. Oncotherapeutics was founded in 1988 and is headquartered in West Hollywood, CA.

TranS1, Inc. designs and develops surgical procedures and equipment for back pain. It is a medical device company focused on designing, developing and marketing products that implement its proprietary approach to treat degenerative conditions of the spine affecting the lower lumbar region. TranS1 currently markets the AxiaLIF family of products for single-level and two-level lumbar fusion and the Vectre and Avatar posterior fixation systems for lumbar fixation supplemental to AxiaLIF fusion. Its primary technology is AxiaLIF, a minimally invasive access and fusion system that enables lumbar fusion to be performed with complete preservation of the annulus and all paraspinal soft tissue structures. The company specializes in bringing innovative spine solutions to market, including AxiaLIF and AxiaLIF 2L+, technologies that allow surgeons to perform lower lumbar fusions that result in high fusion rates and low complication rates. The company is also developing a motion preservation platform to be delivered through this minimally invasive, trans-sacral approach. TranS1 was founded in May 2000 and is headquartered in Wilmington, NC.

Sapient Capital LP is a venture capital fund based in Jackson, DE.